[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP2922507B1 - Adjustable support system - Google Patents

Adjustable support system Download PDF

Info

Publication number
EP2922507B1
EP2922507B1 EP13857489.2A EP13857489A EP2922507B1 EP 2922507 B1 EP2922507 B1 EP 2922507B1 EP 13857489 A EP13857489 A EP 13857489A EP 2922507 B1 EP2922507 B1 EP 2922507B1
Authority
EP
European Patent Office
Prior art keywords
assembly
support
patient
pods
fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP13857489.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2922507A2 (en
EP2922507A4 (en
Inventor
Nikhil Bhat
George Y. Choi
Allen J. Li
Jasper Jackson
Stuart Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PRS MEDICAL TECHNOLOGIES Inc
PRS MEDICAL Tech Inc
Original Assignee
PRS MEDICAL TECHNOLOGIES Inc
PRS MEDICAL Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/683,198 external-priority patent/US9339407B2/en
Priority claimed from US13/693,691 external-priority patent/US9326905B2/en
Priority claimed from US13/760,482 external-priority patent/US20130180530A1/en
Priority claimed from US13/784,035 external-priority patent/US10485691B2/en
Application filed by PRS MEDICAL TECHNOLOGIES Inc, PRS MEDICAL Tech Inc filed Critical PRS MEDICAL TECHNOLOGIES Inc
Publication of EP2922507A2 publication Critical patent/EP2922507A2/en
Publication of EP2922507A4 publication Critical patent/EP2922507A4/en
Application granted granted Critical
Publication of EP2922507B1 publication Critical patent/EP2922507B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/01—Orthopaedic devices, e.g. splints, casts or braces
    • A61F5/0102—Orthopaedic devices, e.g. splints, casts or braces specially adapted for correcting deformities of the limbs or for supporting them; Ortheses, e.g. with articulations
    • A61F5/0104—Orthopaedic devices, e.g. splints, casts or braces specially adapted for correcting deformities of the limbs or for supporting them; Ortheses, e.g. with articulations without articulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
    • A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
    • A61F13/069—Decubitus ulcer bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/01—Orthopaedic devices, e.g. splints, casts or braces
    • A61F5/0102—Orthopaedic devices, e.g. splints, casts or braces specially adapted for correcting deformities of the limbs or for supporting them; Ortheses, e.g. with articulations
    • A61F5/012—Orthopaedic devices, e.g. splints, casts or braces specially adapted for correcting deformities of the limbs or for supporting them; Ortheses, e.g. with articulations inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/01—Orthopaedic devices, e.g. splints, casts or braces
    • A61F5/04—Devices for stretching or reducing fractured limbs; Devices for distractions; Splints
    • A61F5/05—Devices for stretching or reducing fractured limbs; Devices for distractions; Splints for immobilising
    • A61F5/058—Splints
    • A61F5/05816—Inflatable splints
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
    • A61G7/05—Parts, details or accessories of beds
    • A61G7/065—Rests specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
    • A61G7/10—Devices for lifting patients or disabled persons, e.g. special adaptations of hoists thereto
    • A61G7/1073—Parts, details or accessories
    • A61G7/1082—Rests specially adapted for
    • A61G7/109—Lower body, e.g. pelvis, buttocks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F2013/15008—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterized by the use
    • A61F2013/15024—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterized by the use for protecting the body against ulcers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
    • A61G7/05—Parts, details or accessories of beds
    • A61G7/057—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor
    • A61G7/05738—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with fluid-like particles, e.g. sand, mud, seeds, gel, beads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
    • A61G7/05—Parts, details or accessories of beds
    • A61G7/057—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor
    • A61G7/05769—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with inflatable chambers
    • A61G7/05776—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with inflatable chambers with at least two groups of alternately inflated chambers

Definitions

  • the present invention relates to devices for preventing and treating pressure ulcers. More particularly, the present invention relates to devices for preventing and treating pressure ulcers with cushioning devices which are integrated into surfaces on which an individual sits, lies, or stands or are adapted to be applied to such surfaces and easily conformed to various regions of the patient's body by utilizing individual cushioning pods which are supported within an inner fluid pad as well as an outer fluid pad.
  • decubitus ulcers or pressure sores tissue necrosis over localized regions of their body known as decubitus ulcers or pressure sores.
  • pressure ulcers generally occur at locations of the body where the bony prominence is high and the underlying skin breaks down when constant pressure is placed against the skin. Blood circulation is inhibited or prevented in these localized areas and can even occur when the patient has been lying against or upon cushioning devices. Examples of areas of the body where pressure sores typically occur include the sacrum, greater trochanter, ischial tuberosity, malleolus, heel, etc. When pressure ulcers form, they can lead to extensive stays in the hospital or even to amputation.
  • Conventional cushioning devices generally utilize flexible materials such as foam or springs which allow for the cushion to deform and conform to the patient's body. While the cushioning device attempts to redistribute the loading from localized regions of the patient's body to a larger area over the rest of the body, such devices typically bottom out such that the patient's body contacts the underlying platform and nonetheless localizes the pressure onto the body.
  • cushioning devices utilize segmented bladders in an attempt to isolate individual bladders from one another. Yet such segmented cushions may fail to allow for the cushion to fully conform to the patient's body as fluid between each of the segmented cushions is prevented.
  • US 2013/019881 A1 discloses a support assembly similar to that disclosed in conjunction with Figs. 1 to 13 of the present application. It discloses a support assembly comprising an outer shell which is sufficiently flexible to be worn upon a portion of a subject's body.
  • One or more spring assemblies are positioned adjacent to one another upon a first surface of the outer shell.
  • a fluid filled outer pad is positioned upon the inner pad and the first surface of the outer shell.
  • An inner pad encloses the one or more spring assemblies.
  • WO 02/074205 A1 discloses a traction apparatus.
  • the traction apparatus comprises a first traction device and a second traction device.
  • the first traction device and second traction device have a plurality of expandable tubes stacked horizontally, respectively.
  • the first traction device is opposite to the second traction device.
  • the first traction device is provided in a first pocket and the second traction device is provided in a second pocket.
  • the tubes are expandable to provide traction on the therapy region and are filled up with fluid which is generated by a fluid generation device.
  • US 5 843 008 A discloses a device and method for use in mitigating the pain experienced by a patient, after surgery to portions of the patient's torso, when the patient coughs, and for increasing the effectiveness of the patient's cough.
  • the device includes a back portion and two wing portions for compressing a portion of the patient's torso with inward and downward forces.
  • WO 2010/017667 A1 discloses an inflatable belt comprising an inflatable chamber and a connecting device.
  • WO 01/89433 A1 discloses a pelvic compression splint for splinting support and compression of the pelvis.
  • the pelvic compression splint includes: right and left plates to be positioned on the right and left sides, respectively, of the pelvis; right and left inner shells positioned between the right and left plates, respectively, and the right and left side of the pelvis; and a support member for supporting the right and left plates and right and left inner shells compressively against the right and left sides of the pelvis.
  • the owner has provided the support assembly of claim 1. Additional aspects of the invention are set out in the dependent claims.
  • a portable support assembly may be integrated into a piece of furniture on which an individual sits, lies, or stands for an extended period of time to prevent the formation of pressure ulcers.
  • Such a portable support assembly may be configured to conform to particular regions of the body where pressure ulcers tend to form, e.g., sacrum, trochanter, ischium, as well as any other region of the body where support is desired.
  • the portable support assembly may be formed into an elongated shape to be wrapped entirely around the patient's body, e.g., around the hips or lower back, or a portion of the body, e.g., around the ankles or feet.
  • the support assembly may be placed upon a bed, wheelchair, or platform (or directly integrated into the bed, wheelchair, or platform) upon which the patient is resting.
  • the support assembly may be configured to be portable such that it may be worn directly over or upon the patient's body independently from the underlying bed or cushion. Accordingly, the patient may utilize the support assembly on any underlying bed or platform. Additionally, while the examples described illustrate portable support assemblies, the support assembly may be integrated into a bed, underlying cushion, and/or mattress pad if so desired and as previously described.
  • the support assembly may further comprise a mattress, such as a spring mattress, a foam mattress, a low air loss mattress, a segmented air mattress, or a cyclical air pressure mattress.
  • the mattress may include a recess in which the assembly or the outer pad is seated.
  • the support assembly may comprise one or more pods positioned adjacent to one another, an inner pad enclosing the one or more pods such that compression of the pods is controlled by the inner pad, an outer pad enclosing the inner pad, and an outer shell attached to the outer pad, wherein the outer shell is sufficiently flexible to be worn upon a portion of a subject's body.
  • the support assembly may support the desired region of the body by securing a portable support assembly directly to the region of the body to be supported, controlling displacement of one or more pods positioned along the support assembly beneath the region via an inner pad enclosing the one or more pods, and redistributing a pressure load from the one or more pods and inner pad to an outer pad positioned along the support assembly and enclosing the inner pad, wherein the redistributed pressure load is exerted upon the body surrounding the supported region.
  • the portable support assembly may generally define a securement area for placement against the region of the body requiring support such as the sacrum.
  • the securement area may generally comprise a central portion with a first conformable portion and/or second conformable portion extending from either side of the central portion.
  • the first and/or second conformable portions may be flexible enough to allow for the portions to be wrapped around or about at least a portion of the patient's body such that the assembly may remain secured to the body even when the patient moves about thereby maintaining the central portion against the supported region of the body.
  • the central portion may provide the greatest amount of localized support to the patient body by utilizing several fluid layers which are contained one within another to receive the localized loading from the protuberance from the patient's body and distribute the localized load onto the surrounding areas and to further control displacement or inhibit or prevent the bottoming out of the fluid layers.
  • the central portion may thus contain one or more fluid filled individual pods which may be enclosed entirely within an inner fluid pad which envelopes the one or more pods within a secondary layer of fluid.
  • the inner fluid pad may be localized along the central portion. Both the one or more pods and inner fluid pad are then enclosed entirely by a tertiary layer of fluid within an outer fluid pad which may extend over the entire assembly.
  • Each of the fluid layers may be secured to an outer shell which is relatively stiffer than the fluid layers and may restrict or limit the expansion or movement of the fluid pods and/or fluid pads. While the assembly is adjustable to fit a particular patient, the outer pad, in particular, may optionally be filled with the fluid to a variable amount to further ensure that the assembly may be fitted or conformed to the anatomy of a particular patient.
  • Each of the one or more pods may be separated from one another such that no fluid communication occurs between the pods and/or with the inner pad.
  • the inner pad may be separate from the outer pad such that no fluid communication occurs between the two.
  • some fluid communication may occur between the inner pad and outer pad so long as the inner pad constrains and prevents the over-compression of the one or more pods to control their displacement and inhibit their bottoming out.
  • Each of the pods and/or fluid pads may be filled with an incompressible fluid such as water, viscous oil, or some other biocompatible fluid. Yet in other variations, the pods and/or fluid pads may be filled alternatively with a gas such as air, nitrogen, etc. In yet additional variations, the one or more pods and/or fluid pads may be filled with either a fluid or gas or a combination of both depending upon the desired degree of cushioning and force distribution.
  • the fluid may be a low density fluid with a specific gravity of less than 0.9 or with a specific gravity of less than 0.7.
  • the pods and/or fluid pads may contain solids in addition to fluid. Examples of such solids include glass microspheres. The solid may have a specific gravity of less than 0.9 or less than 0.7. Using low density materials can reduce the weight of the apparatus without reducing its size.
  • the one or more fluid pods may each occupy an envelope of, e.g., 1 cm x 1 cm x 0.5 cm to about 3 cm x 3 cm x 3 cm, in an uncompressed state and they may be formed into various shapes, e.g., spherical, cylindrical, cubical, etc. Moreover, each of the pods may be formed from various materials such as polyurethane, silicone, vinyl, nylon, polyethylene vinyl acetate (PEVA), etc. having a thickness ranging from, e.g., 0.1 mm to 5 mm. Although the figure illustrates four pods, the number of pods contained within the inner pad may range anywhere from, e.g., 1 to 30 or more, arranged either uniformly or arbitrarily within the inner pad. Additionally, while the pods may be unconstrained within the inner pad such that they freely move relative to one another, the pods may be secured within the inner pad either to one another or to the inner pad itself such that their relative movement is constrained.
  • PEVA polyethylene vinyl a
  • one or more spring assemblies may be used to provide the cushioning support.
  • These spring assemblies may utilize various spring types such as leaf or compression springs or various other types of biasing mechanisms.
  • the pods may transfer localized loads from the patient received by a few pods either to adjacent pods through the compression and transfer of pressure to adjacent contacting pods or through transmission via the fluid in the inner pad and/or outer pad.
  • the amount of compression of the pods themselves may be controlled by the inner pad which envelopes the pods within a pad localized over the central portion.
  • the inner pad may function as a hammocking layer to constrain the amount of displacement experienced by the individual pods but because the inner pad itself may be fluid filled, the inner pad may further provide support to the patient's body while also restricting compression of the pods.
  • the amount of compression experienced by the individual pods may thus be controlled by the inner pad to range anywhere from, e.g., 0% to 90% (or 10% to 90%), of the uncompressed height of the pods.
  • the inner pad may be sized into various configurations depending upon, e.g., the number of pods or the area of the body to be supported. Moreover, the inner pad may also be made from the same or similar material as the pods, e.g., polyurethane, silicone, vinyl, nylon, polyethylene vinyl acetate (PEVA), etc. While the inner pad may be filled with a fluid (or gas or combination of both), as described above, the inner pad may alternatively be devoid of fluid and instead be used to constrain the expansion of the individual pods. Thus, inner pad may be optionally vented to allow for any trapped air to vent from between the pods when the pods undergo compression.
  • a fluid or gas or combination of both
  • an additional outer pad may enclose and surround the inner pad which further encloses the one or more pods.
  • the outer pad may be similarly filled with a fluid or gas (or combination of both), as described above, and may be enclosed by a layer of material either the same or similar to the material of the inner pad and/or pods and further have a uniform or variable thickness ranging from, e.g., 0.5 mm to 4 cm.
  • the outer pad may further constrict the compression of the inner pad which in turn constricts the compression of the one or more pods while additionally providing cushioning support to the surrounding tissue or body structures.
  • the outer pad may further extend over the length of the entire assembly to provide cushioning support to the region of the body upon which the assembly is secured.
  • the outer shell which may function as a restricting support to control displacement and inhibit the further compression of the outer pad to prevent the patient's body from bottoming out.
  • the outer shell may be formed on a single side of the assembly such that when the assembly is worn or used by the patient, the outer shell may be positioned away from the skin of the patient such that the outer pad remains in contact with the patient.
  • the outer shell may be accordingly made to be relatively stiffer than the outer pad yet still be flexible enough for conforming over or around the patient's body. Accordingly, the outer shell may be made from materials including plastics such as polypropylene, ABS, PVC, polyethylene, nylon, acrylic, polycarbonate, etc.
  • the outer shell may also be fabricated from other materials such as polymers, carbon fiber, light weight metals, elastomeric materials, rubbers, foams, etc. Depending upon the material used, the outside shell can have a thickness ranging from, e.g., 1 mm to 3 cm.
  • the one or more fluid filled pods may thus support the body portion (such as the sacrum or trochanter) and due to the weight of the patient, the one or more pods may compress against one another by a limited amount. However, the one or more pods may be inhibited from bottoming out due to the surrounding hammocking inner pad. The pressure on the body portion may thus be reduced and distributed/transferred to the surrounding fluid present in the inner pad. Moreover, the presence of the surrounding outer pad may further transmit and redistribute the induced pressure upwards towards and against the surrounding body portions, such as the thigh area. This decrease in pressure can lead to a reduction in pressure against the localized body region to a value of less than or approximately 4.3 kPa and hence prevent tissue necrosis and reduce the occurrence of pressure ulcers.
  • an assembly may further incorporate additional localized support regions along different portions of the assembly.
  • Other variations of the assembly may incorporate baffles and other mechanisms to optionally create interconnected fluid regions. These regions may allow for reducing the amount of fluid in the entire system and prevent the fluid from pooling in one area.
  • open cell foam may be placed between the individual inner and outer fluid layers. This foam layer may be saturated with fluid and allow for the transfer of fluid pressure between the different fluid layers.
  • Additional variations may incorporate a breathable layer covering at least a portion of the outer pad.
  • the layer may be porous and can be made from materials such as cotton, etc., such that air may circulate through the pores or openings.
  • one or more vibrating elements may be attached or integrated into the assembly, e.g., along the outer layer of the outer pad. These vibrating elements may vibrate to impart micro or macro vibrations directly against the contacted skin surface to relieve pressure over the contact area or into the fluid pad itself to indirectly vibrate against the skin surface.
  • the vibrating elements may generate micro-vibrations on the order of about, e.g., 10 to 500 microns, in amplitude with a frequency ranging from about, e.g., 10 Hz to 300 Hz. These vibrations may allow for increased blood circulation and may also help decrease the incidence of pressure ulcers.
  • the vibrating elements may be comprised of piezoelectric, nitinol, or any other actuator driven elements.
  • any of the embodiments described herein may incorporate various temperature control mechanisms. These may include one or more regions within the support pad assemblies which may be cooled and/or heated to prevent and/or treat pressure ulcers.
  • One variation may include a support assembly having a central support which incorporates a fabric portion.
  • a first support portion and a corresponding second support portion on an opposite side may each be angularly coupled to central portion and a separate back support portion may also be coupled to the central support.
  • the central portions as well as support portions and back support portion may be comprised of a conformable material (e.g., malleable metal such as aluminum or plastics, foams, or any other bendable material) which is relative stiffer than the fabric portion and inner or outer pads.
  • the supporting portions may provide adequate support to a patient when the assembly is placed, e.g., upon a mattress or platform, while enabling the assembly to bend or flex into placement against the patient body when the patient lies upon the assembly.
  • the support portions may incorporate a corresponding first conformable portion and second conformable portion fabricated from a stretchable or distendible material such as a mesh or fabric which is supported by one or more adjustable straps (e.g., straps with hook-and-loop fastening portions) coupling the conformable portions to their respective support portions.
  • adjustable straps e.g., straps with hook-and-loop fastening portions
  • the flexibility of the conformable portions may enable the shell assembly to shape or conform more closely to the patient body and may also provide for enhanced comfort.
  • the support portions may be attached to the central portion via one or more adjustable cords (e.g., bungee cords) columns pivotably attached to a platform and extending into connection with one or more openings within the respective support portions.
  • the supporting side portions may be comprised of composite assemblies which are adjustably configurable.
  • the composite assembly may generally include a number of individual support elements (e.g., plastic, metal, foam, etc.) which are connected to one another along respective longitudinal axes in an alternating pattern.
  • a tensioning member such as a wire, screw, etc., may be passed through each end of the support elements along the longitudinal axes with a tightening member coupled at the ends of the tensioning member.
  • the support portions may be comprised of angled supports which are adjustably secured to respective first and second adjustable supports which may be rotatable about first and second pivots.
  • the adjustable supports may each support respective first and second conformable portions which provide a surface for supporting the bladder assembly against the patient.
  • the conforming supports may extend in a curved or arcuate manner from the central support portion in a shaped shell configuration.
  • the conforming supports may extend in strips or members which are shaped, e.g., like flower petals, and the supports may be secured in place using any number of securement mechanisms, e.g., friction hinge mechanisms, electromechanical locking systems, hydraulic locking systems, magnetic locking systems, electro or magneto-rheological locking systems, etc.
  • any of the outer shell assemblies may incorporate one or more zones throughout various regions of the shell which may selectively or simultaneously squeeze, vibrate, or otherwise actuate. These selective zones may vibrate at a selected frequency and/or amplitude and may be actuated at fixed intervals or times.
  • outer shell assembly may include conforming supports which extend in a curved or arcuate shape for conforming more closely against the patient's body.
  • the supports may each integrate one or more support members which are adjacent to respective sliding supports which may be tuned to push in or out relative to the central support portion to adjust a rotation or bend radius of each support independently of one another or simultaneously with each support.
  • the fluid within the pad may be redistributed to reduce any pressure that may result below any bony prominences of the patient body.
  • the presence of muscle mass and soft tissue ST usually functions to distribute and relieve pressure from bony protuberances of the body contacted against the underlying surface.
  • areas such as the sacrum SA or trochanter TR may compress a region of the skin SK and tissue 12 between the protuberance and a contact region 10 formed against the underlying surface, as shown in Fig. 1A .
  • Typical pressures generated in the hip area for healthy individuals lying against a surface may range around 4 kPa.
  • the contact pressures between regions of bony prominence and the skin is generally higher due to various factors such as muscle atrophy. For instance, increased pressures were found to range around 7.3 kPa for such older individuals. Blood circulation becomes restricted and tissue necrosis typically begins when pressures range above 4.3 kPa leading to the development of pressure ulcers.
  • a portable support assembly 14 may be worn or used by an individual who may be bed-stricken for an extended period of time to prevent the formation of pressure ulcers.
  • Such a portable support assembly 14 may be worn by the individual around particular regions of the body where pressure ulcers tend to form, e.g., sacrum SA , trochanter TR, ischium, as well as any other region of the body where support is desired.
  • the portable support assembly 14 may be formed into an elongated shape to be wrapped entirely around the patient's body, e.g., around the hips or lower back, or a portion of the body, e.g., around the ankles or feet.
  • Fig. 1B illustrates the assembly 14 placed around the trochanter TR or sacrum SA
  • other embodiments may include various shapes of the assembly 14 which may be sized for particular body regions and are intended to be within the scope of this disclosure.
  • the support assembly 14 is configured to be portable such that it may be worn directly over or upon the patient's body independently from the underlying bed or cushion. Accordingly, the patient may utilize the support assembly 14 on any underlying bed or platform. Additionally, while the examples described illustrate portable support assemblies, the support assembly may be integrated into a bed, underlying cushion, and/or mattress pad if so desired.
  • the support assembly 14 may generally define a securement area 16 for placement against the region of the body requiring support such as the sacrum SA .
  • the securement area 16 may generally comprise a central portion 20 with first conformable portion 18A and/or second conformable portion 18B extending from either side of the central portion 20.
  • the first and/or second conformable portions 18A, 18B may be flexible enough to allow for the portions 18A, 18B to be wrapped around or about at least a portion of the patient's body such that the assembly 14 may remain secured to the body even when the patient moves about thereby maintaining the central portion 20 against the supported region of the body.
  • the central portion 20 may provide the greatest amount of localized support to the patient body by utilizing several fluid layers which are contained one within another to receive the localized loading from the protuberance from the patient's body and distribute the localized load onto the surrounding areas and to further control their displacement and inhibit or prevent the bottoming out of the fluid layers.
  • the central portion 20 may thus contain one or more fluid filled individual pods 28 which may be enclosed entirely within an inner pad 24 which envelopes the one or more pods 28 within a secondary layer of fluid.
  • the inner pad 24 may be localized along the central portion 20.
  • the inner pad 24 may be filled with a fluid (or gas) or optionally be devoid of any fluid, as described in further detail below.
  • Both the one or more pods 28 and inner pad 24 are then enclosed entirely by a tertiary layer of fluid within an outer pad 26 which may extend over the entire assembly 14.
  • Each of the fluid layers may be secured to an outer shell 22 which is relatively stiffer than the fluid layers and may restrict or limit the expansion or movement of the fluid pods 28 and/or pads 24, 26.
  • the outer pad 26, in particular may optionally be filled with the fluid to a variable amount to further ensure that the assembly 14 may be fitted or conformed to the anatomy of a particular patient.
  • Each of the one or more pods 28 may be separated from one another such that no fluid communication occurs between the pods 28 and/or with the inner pad 24.
  • the inner pad 24 may be separate from the outer pad 26 such that no fluid communication occurs between the two.
  • some fluid communication may occur between the inner pad 24 and outer pad 26 so long as the inner pad 24 constrains and prevents the over-compression of the one or more pods 28 to control their displacement and inhibit their bottoming out.
  • Each of the pods 28 and/or fluid pads 24, 26 may be filled with an incompressible fluid such as water, salt solution, viscous oil, or some other biocompatible fluid. Yet in other variations, the pods 28 and/or fluid pads 24, 26 may be filled alternatively with a gas such as air, nitrogen, etc. In yet additional variations, the one or more pods 28 and/or fluid pads 24, 26 may be filled with either a fluid or gas or a combination of both depending upon the desired degree of cushioning and force distribution. In some embodiments, the fluid that fills the pods 28 and or fluid pads 24, 26 may be a liquid or flowable semisolid to reduce the amount of leakage relative to that observed with use of a gas.
  • the one or more fluid pods 28 may each occupy an envelope of, e.g., 1 cm x 1 cm x 0.5 cm to about 3 cm x 3 cm x 3 cm or even 35 cm x 5 cm x 5 cm, in an uncompressed state and they may be formed into various shapes, e.g., spherical, cylindrical, cubical, etc. Moreover, each of the pods may be formed from various materials such as polyurethane, silicone, vinyl, nylon, polyethylene vinyl acetate (PEVA), etc. having a thickness ranging from, e.g., 0.1 mm to 5 mm.
  • PEVA polyethylene vinyl acetate
  • the number of pods 28 contained within the inner pad 24 may range anywhere from, e.g., 1 to 30 or more (such as 2 to 100), arranged either uniformly or arbitrarily within the inner pad 24. Additionally, while the pods 28 may be unconstrained within the inner pad 24 such that they freely move relative to one another, the pods 28 may be secured within the inner pad 24 either to one another or to the inner pad 24 itself such that their relative movement is constrained.
  • the pods 28 may transfer localized loads from the patient received by a few pods 28 either to adjacent pods through the compression and transfer of pressure to adjacent contacting pods or through transmission via the fluid in the inner pad 24 and/or outer pad 26.
  • the amount of compression of the pods 28 themselves may be controlled by the inner pad 24 which envelopes the pods 28 within a pad localized over the central portion 20.
  • the inner pad 24 may function as a hammocking layer to constrain the amount of displacement experienced by the individual pods 28 and provide an increase in the net force constant relative to the force constant due to compression of the individual pods 28. This increase in net force may be due to pressure applied by inner pad directly on the surfaces of the individual pods 28 and/or due to force applied through the fluid that fills the inner pad 24.
  • the inner pad 24 may further provide support to the patient's body while also restricting compression of the pods 28.
  • the amount of compression experienced by the individual pods 28 may thus be controlled by the inner pad 24 to range anywhere from, e.g., 0% to 90% (or 10% to 90%), of the uncompressed height of the pods 28.
  • the compression of the pod 28 may range anywhere from, e.g., 0 cm to 2.7 cm (or 0.3 cm to 2.7 cm).
  • the inner pad 24 may be sized into various configurations depending upon, e.g., the number of pods 28 or the area of the body to be supported. Moreover, the inner pad 24 may also be made from the same or similar material as the pods 28, e.g., polyurethane, silicone, vinyl, nylon, polyethylene vinyl acetate (PEVA), etc. While the inner pad 24 may be filled with a fluid (or gas or combination of both), as described above, the inner pad 24 may alternatively be devoid of fluid and instead be used to constrain the expansion of the individual pods 28. Thus, inner pad 24 may be optionally vented to allow for any trapped air to vent from between the pods 28 when the pods 28 undergo compression.
  • PEVA polyethylene vinyl acetate
  • an additional outer pad 26 may enclose and surround the inner pad 24 which further encloses the one or more pods 28.
  • the outer pad 26 may be similarly filled with a fluid or gas (or combination of both), as described above, and may be enclosed by a layer of material either the same or similar to the material of the inner pad 24 and/or pods 28 and further have a uniform or variable thickness ranging from, e.g., 0.5 mm to 4 cm.
  • the outer pad 26 may further constrict the compression of the inner pad 24 which in turn constricts the compression of the one or more pods 28 while additionally providing cushioning support to the surrounding tissue or body structures.
  • the outer pad 26 may further extend over the length of the entire assembly 14 to provide cushioning support to the region of the body upon which the assembly 14 is secured.
  • the outer pad 26 may have a thickness ranging anywhere from, e.g., 5 mm to 2 cm or more (such as in areas in contact against the sacrum)
  • the inner pad 24, outer pad 26, and/or pods 28 may be filled with a fluid having a density which is relatively higher than the density of a body.
  • the density of the human body is about 1.01 g/cm 2 and a salt solution filled within any of the pads 24,26 and/or pods 28 can have density of, e.g., 1.03 to 1.1 g/cm 2 .
  • the fluid may have a low density of, e.g., 0.3 to 0.9 g/cm 3 or 0.5 to 0.7g/cm 3 .
  • the outer shell 22 which may function as a restricting support to control displacement and inhibit the further compression of the outer pad 26 to prevent the patient's body from bottoming out.
  • the outer shell 22 may be formed on a single side of the assembly 14 such that when the assembly 14 is worn by the patient, the outer shell 22 may be positioned away from the skin of the patient such that the outer pad 26 remains in contact with the patient.
  • the outer shell 22 may be accordingly made to be relatively stiffer than the outer pad 26 yet still be flexible enough for conforming over or around the patient's body.
  • the outer shell 22 may be rigid to provide additional support. Accordingly, the outer shell 22 may be made from materials including plastics such as polypropylene, ABS, PVC, polyethylene, nylon, acrylic, polycarbonate, etc.
  • the outer shell 22 may also be fabricated from other materials such as polymers, carbon fiber, light weight metals, foams, etc. Depending upon the material used, the outside shell 22 can have a thickness ranging from, e.g., 1 mm to 3 cm or more.
  • the one or more fluid filled pods 28 may thus support the body portion (such as the sacrum SA or trochanter TR ) and due to the weight of the patient, the one or more pods 28 may compress against one another by a limited amount. However, the one or more pods 28 may be inhibited from bottoming out due to the surrounding hammocking inner pad 24. The pressure on the body portion may thus be reduced and distributed/transferred to the surrounding fluid present in the inner pad 24. Moreover, the presence of the surrounding outer pad 26 may further transmit and redistribute the induced pressure upwards towards and against the surrounding body portions, such as the thigh area. This decrease in pressure can lead to a reduction in pressure against the localized body region to a value of less than or approximately 4.3 kPa and hence prevent tissue necrosis and reduce the occurrence of pressure ulcers.
  • the one or more pods 28 may be connected directly to the outer shell 22 and contained by the hammocking inner pad layer 24 which prevents the pods 28 from bottoming out, as described above.
  • the outer fluid pad 26 may be laid atop the one or more pods 28 and hammocking inner layer 24.
  • the one or more pods 28 (contained within the hammocking inner layer 24 ) may come into direct contact against the patient and the outer fluid pad 26 may instead be attached directly to the outer shell 22.
  • Fig. 3 shows a cross-sectional view of an assembly which is similarly constructed to the variation of Fig. 2 but which may further incorporate additional localized support regions.
  • a first fluid inner pad 30A having one or more pods 32A contained within may be integrated along the first conformable portion 18A extending from the central portion 20.
  • a second fluid inner pad 30B having one or more pods 32B contained within may be integrated along the second conformable portion 18B extending from the opposite side of the central portion 20.
  • the conformable portions 18A, 18B may be wrapped or secured against the hips of the patient such that the corresponding inner pads 30A, 30B are positioned over either or both trochanters TR of the patient while the central portion 20 is positioned over the sacrum SA to provide support around the entire hip and lower back regions of the patient.
  • the number and size of the pods 32A, 32B may be varied.
  • the inner layer 24 may be compliant or non-compliant. The inner layer 24 may be compliant on the selected surfaces, such as those contacting the patient, while non-compliant on other surfaces, such as surfaces substantially perpendicular to the surfaces contacting the patient.
  • the support assembly 14 may be sized in various configurations depending upon the region of the body to which the assembly is to be positioned, another example of an assembly configuration is shown in the perspective views of Figs. 4A and 4B .
  • the support system may be configured as a hinged fluid pad assembly 40 having a central portion 42 and a first foldable portion 44A and a second foldable portion 44B extending from either side of the central portion 42.
  • the outer shell of the foldable portions 44A, 44B may be coupled via corresponding first hinged region 46A and second hinged region 46B such that the assembly 40 may be laid flat upon a bed or platform.
  • the inner fluid pad 24 and one or more pods 28 may be positioned upon the central portion 42 and/or optionally along the first and/or second foldable portions 44A, 44B as well while the outer pad 26 may extend continuously along the length of the entire assembly 40. In use, the assembly 40 may be laid flat and folded over upon or against the patient's body and secured accordingly.
  • baffles and other mechanisms may incorporate baffles and other mechanisms to optionally create interconnected fluid regions. These regions may allow for reducing the amount of fluid in the entire system and prevent the fluid from pooling in one area.
  • open cell foam may be placed between the individual inner and outer fluid layers. This foam layer may be saturated with fluid and allow for the transfer of fluid pressure between the different fluid layers.
  • Fig. 5 shows a perspective view of yet another variation in which the support assembly 50 may incorporate a breathable layer covering at least a portion of the outer pad 26.
  • the layer may be porous and can be made from materials such as cotton, etc., such that air may circulate through the pores or openings 52.
  • a pump 54 coupled via a fluid line 56 may be optionally attached to the assembly 50 to pump air through the pores or openings 52.
  • one or more vibrating elements 58 may be attached or integrated into the assembly 50, e.g., along the outer layer of the outer pad 26. These vibrating elements 58 may vibrate to impart micro or macro vibrations directly against the contacted skin surface to relieve pressure over the contact area or into the fluid pad itself to indirectly vibrate against the skin surface.
  • the vibrating elements 58 may generate micro-vibrations on the order of about, e.g., 10 to 500 microns, in amplitude with a frequency ranging from about, e.g., 10 Hz to 300 Hz. These vibrations may allow for increased blood circulation and may also help decrease the incidence of pressure ulcers.
  • the vibrating elements 58 may be comprised of piezoelectric, nitinol, or any other actuator driven elements.
  • the assembly 50 may be integrated with an optional mattress topper 54 to provide stability to the assembly 50 when positioned against the patient.
  • the support assembly may utilize one or more spring assemblies in combination with the inner pad 24 and/or outer pad 26 rather than using the one or more pods 28.
  • An example is shown in the perspective view of Fig. 6A which shows a variation of the assembly with outer pad 26 positioned atop one or more spring assemblies 60 rather than one or more pods.
  • Fig. 6B shows a partial cross-sectional side view of one or more spring assemblies 60 secured upon the outer shell 22 and the outer pad 26 positioned atop the spring assemblies 60.
  • the number of individual compression assemblies 60 in the array can vary, e.g., from 1 to 25 or more depending upon the desired treatment area.
  • each of the individual spring assemblies 60 is designed to be non-bottoming and further designed to reduce the pressure to less than or equal to, e.g., 32 mm of Hg, when a person uses the system.
  • a spring assembly may have an individual base 62 for securement to the outer shell 22 and a corresponding top layer 66 for contacting against the outer pad 26 and/or directly against the patient body. Between the top layer 66 and base 62 are one or more biasing members 64, e.g., spring elements.
  • biasing members 64 e.g., spring elements.
  • An example is shown in the perspective view of Fig. 7 which illustrates the top layer 66 and base 62 formed in a circular configuration although they may be formed in any number of shapes which are suitable for placement between the shell 22 and outer pad 26.
  • the variation of biasing members 64 shown may comprise superelastic shape memory alloys such as heat-formed Nitinol formed, e.g., into flattened strips of material which are configured into leaf or compression springs, as shown.
  • the spring assembly shown in Fig. 7 is illustrated as having four biasing members 64 but the assembly can have one, two, three, or more biasing members 64.
  • the biasing members 64 can also be made from other materials such as stainless steels, plastics, elastomers, and other suitable materials.
  • Fig. 8 shows an alternative variation of a spring assembly having a base 70 and a top layer 72 with the biasing members 74 as previously described.
  • the assembly may further have one or more post members 76 extending from the base 70 for translational engagement with one or more corresponding guide members 78 which may be aligned to receive the post members 76.
  • the post members 76 may prevent the top layer 72 from rotating out of alignment with respect to base 70 during use.
  • the biasing members 74 may be designed to be a multiple prong anchor or flower design although any of the spring designs described herein may be used.
  • the individual spring assembly can have a surface area, e.g., from 0.5 to 1.0 cm 2 or even up to 200 cm 2 , and an uncompressed height ranging from, e.g., 1 cm to 3 cm.
  • the biasing members 64 can also vary from having a constant force to having compression systems with a single spring constant or multiple spring constants.
  • biasing elements such as extension springs, leaf springs, torsion springs, or any formed or shaped design which can accomplish similar functions may be used.
  • the different kinds of springs and compression pods may be designed to have spring constants either independently or on a system level such that the displacement or travel to support the patient does not result in pressures greater than, e.g., 4.3 kPA or similar pressures, which can cause tissue necrosis and lead to formation of pressure ulcers.
  • FIG. 9A shows a side view of a leaf spring 80 while Figs. 9B and 9C show side views of a conical spring 82 and a cylindrical spring 84, respectively, which may be used as well.
  • Fig. 9D shows a perspective view of an elastomeric spring 86 which may also be used, if so desired.
  • Tests using exemplary embodiments of the support assembly described herein have been conducted utilizing an array of individual fluid pods enclosed within an inner enveloping pad. This assembly was then enveloped within an outer fluid pad where both the fluid pods and outer pads were filled with water. The assembly was positioned near a simulated sacrum region and a similar arrangement was positioned near a simulated trocanter region.
  • An artificial male hip model was used to which a 0 to 20 lb FLEXIFORCE® (Tekscan, Inc., MA) sensor was attached to the sacrum region of the hip model.
  • the FLEXIFORCE® sensor was used to sense contact force/pressure and an 8 lb load (ball) was used as the simulated load of a patient.
  • FIG. 15A Another exemplary embodiment of the support assembly (such as the variation shown in Fig. 15A ) was tested on a mannequin positioned within the support assembly.
  • the mannequin was further weighed down to increase the amount of weight placed against the support assembly.
  • a measurement of the weighted mannequin was also observed upon a standard mattress without the support assembly for comparison purposes.
  • Pressure sensors were used to record the resulting peak pressure measurements upon the mattress and upon the support assembly as well. Additionally, the overall area of contact between the mannequin and the mattress and between the support assembly was also recorded via a pressure map.
  • any of the variations described herein may also incorporate the use of temperature modulation and control to further help prevent the formation of pressure ulcers.
  • the support assembly pad may be controlled to have a temperature which is lower than body temperature to help prevent the formation of pressure ulcers while having an assembly pad controlled to have a temperature which is higher than body temperature can be used to treat pressure ulcers which have already formed upon the body.
  • the assembly pad can be configured to control the contacted skin/tissue temperature to within ⁇ 10° C of body temperature.
  • bidirectional temperature control can be achieved (selectively or alternatively heating and/or cooling). This allows the same assembly pad to be used for prevention and treatment of pressure ulcers. Temperature control can be achieved using any of several various methods and mechanisms.
  • Fig. 10 which illustrates an assembly pad having several individual temperature regions 92A, 92B, 92C, 92D which may be controlled individually or simultaneously to heat or cool specified regions of the pad assembly.
  • Each of the temperature regions may be in electrical communication with a controller 90, e.g., processor, which may be integrated with the pad assembly or arranged as a separate mechanism.
  • Fig. 11 shows another variation where single temperature region 94 may be integrated over the pad assembly to heat or cool the entire pad assembly in contact with the patient.
  • the unidirectional or bidirectional temperature control may utilize any number of temperature altering mechanisms.
  • thermoelectric cooling and heating elements e.g., Peltier junctions
  • resistive heating and cooling elements may be used.
  • inductive heating and cooling elements may also be used.
  • chemically cooling and/or heating reacting materials e.g., exothermic and/or endothermic
  • a cooling or heating fluid may be pumped in a circulating manner with an externally located cooling and/or heating mechanisms in fluid communication with a pumping mechanism.
  • the pad assembly may be designed for alternative uses.
  • the pad may be configured for use by a patient sitting in a wheelchair, standard chair, or other sitting, standing or sleeping devices or platforms.
  • An example of a simplified pad assembly 100 is shown in the perspective view of Fig. 12 .
  • a pad assembly 110 shown in Fig. 13 may be configured for resting, e.g., during surgery, beneath an extremity such as an elbow or any other portion of the body which may come into contact against a hard surface for an extended period of time.
  • the configured pad 110 may cushion, e.g., the ulnar nerve and may include a flat pad with a single fluid pod, for instance.
  • a support assembly 120 which is designed to confine and conform a fluid bladder to the anatomical features of the patient body (such as hip region, sacrum region etc.) is shown.
  • the support assembly 120 may generally comprise a central support 122 having a first central portion 122A and a second central portion 122B coupled to one another via a fabric portion 124.
  • An additional first support portion 126A and a corresponding second support portion 126B on an opposite side may each be angularly coupled to a respective first and second central portion 122A, 122B.
  • a separate back support portion 128 may also be coupled to the central support 122, e.g., either to the central portions 122A, 122B and/or fabric portion 124. Additionally, optional connecting conformable portions 134A, 134B may also be coupled to one or both sides of the back support portion 128 to respective support portions 126A, 126B.
  • the central portions 122A, 122B as well as support portions 126A, 126B and back support portion 128 may be comprised of a conformable material (e.g., malleable metal such as aluminum or plastics, foams, or any other bendable material) which is relative stiffer than the fabric portion 124 and inner or outer pads.
  • the supporting portions may provide adequate support to a patient when the assembly 120 is placed, e.g., upon a mattress or platform, while enabling the assembly 120 to bend or flex into placement against the patient body when the patient lies upon the assembly 120.
  • the support portions 126A, 126B may incorporate a corresponding first conformable portion 130A and second conformable portion 130B fabricated from a stretchable or distendible material such as a mesh or fabric which is supported by one or more adjustable straps 132 (e.g., straps with hook-and-loop fastening portions) coupling the conformable portions 130A, 130B to their respective support portions 126A, 126B.
  • adjustable straps 132 e.g., straps with hook-and-loop fastening portions
  • a correlation may be formed between the amount of squeezing or tightening of the assembly 120 upon the patient body and the amount of pressure provided beneath the patient body. For example, if the conformable portions 130A, 130B are squeezed against the patient body a higher pressure can be generated resulting in tightness against the body. This tightness is a variable which can be calculated based on various factors such as the patient's weight, height, etc. Additionally, the pressure can also be correlated to the fluid pressure inside of the inner and/or outer pads.
  • the back support portion 128 may be coupled via a flexible hinge portion 136 which allows the back support portion 128 to be flexed or angled relative to the central support 122 which may allow the assembly to remain attached securely to the patient as they sit up or lie down.
  • the adjustable straps 132 may also provide stability to the assembly and may also prevent or inhibit the support portions 126A, 126B from falling from the patient body.
  • Figs. 15A and 15B show perspective views of the assembly 120 having a bladder assembly 140 positioned upon the assembly 120 for supporting the patient body along the securement area 138, as described herein.
  • the bladder assembly 140 may comprise the fluid assembly described above generally having an inner pad 142 surrounding the one or more pods 146 and an outer pad 144 which may either encompass the inner pad 142 and pods 146 or which may be laid upon the inner pad 142 and/or pods 146.
  • the pods 146 may be positioned along the central portion 122 and/or along one or both conformable portions 130A, 130B.
  • bladder assembly 140 may also incorporate one or more relief areas 148 which allow a portion of the bladder assembly 140 to bend or flex along with back support portion 128 when angled relative to the central portion 122.
  • FIG. 16 Another variation of the outer shell support assembly is shown in the perspective view of Fig. 16 .
  • the assembly shown may be similarly be used with any of the fluid pad assemblies described herein (not shown for clarity purposes).
  • a central portion 122 may similarly be coupled to a back support portion 128 and support portions 126A, 126B.
  • the support portions 126A, 126B may be further attached to the central portion 122 via one or more adjustable cords 150A, 150B, 150C, 150D (e.g., bungee cords).
  • the flexible cords may help to maintain a position of support portions 126A, 126B relative to central portion 122, particularly when a patient is lying within or upon the shell assembly and pushing outwardly against the shell.
  • the cords may be attached via attachment points 156 (e.g., along central portion 122) and extend over or through the support portions 126A, 126B through corresponding guide 152 and may further be removably coupled to the assembly via an adjustable mechanism 154 which allows for tension adjustment to cords to correspondingly adjust the amount of force or pressure of the support portions 126A, 126B against the patient's body.
  • attachment points 156 e.g., along central portion 122
  • the cords may be attached via attachment points 156 (e.g., along central portion 122) and extend over or through the support portions 126A, 126B through corresponding guide 152 and may further be removably coupled to the assembly via an adjustable mechanism 154 which allows for tension adjustment to cords to correspondingly adjust the amount of force or pressure of the support portions 126A, 126B against the patient's body.
  • FIGs. 17A to 17C show front and perspective views of yet another variation of the supporting shell assembly (the bladder assembly has been omitted for clarity).
  • This variation may similarly include an outer shell assembly having a central portion 122 with respective support portions 126A, 126B angled relative to the central portion 122.
  • this variation may incorporate columns 162 pivotably attached 164 to a platform 160 and extending into connection with one or more openings 166 within respective support portions 126A, 126B.
  • the columns 162 may be pivoted via attachment 164 at a first end and into the one or more openings or receiving channels 166 at a second end to adjust an angle of respective support portions 126A, 126B relative to the central portion 122.
  • the columns 162 themselves may be adjustable in their height to vary the angle of the support portions 126A, 126B relative to the central portion 122.
  • the columns 162 may be adjustably telescoping to vary their height or the columns 162 may be simply interchangeable between columns of different heights.
  • the outer shell assembly shown may incorporate any of the other features described herein in any number of combinations.
  • the central portion 122 may incorporate a meshed portion and/or a back support portion as well as any number of different combinations of the bladder assembly having the one or more pods positioned variously.
  • Fig. 18 shows a perspective view of yet another variation where the central portion 122 may incorporate respective composite assemblies 170A, 170B which are adjustably configurable.
  • the composite assembly may generally include a number of individual support elements 172 (e.g., plastic, metal, foam, etc.) which are connected to one another along respective longitudinal axes 176, 178 in an alternating pattern.
  • a tensioning member 174 such as a wire, screw, etc., may be passed through each end of the support elements 172 along the longitudinal axes 176, 178 with a tightening member 180 coupled at the ends of the tensioning member 174.
  • Loosening of the tightening member 180 may allow for the rotation of the individual support elements 172 with respect to one another such that the composite assemblies 170A, 170B may be conformed desirably to the patient's body to closely follow the anatomy. Once a desirable configuration is conformed, the tightening member 180 may be tightened to force or urge the support elements 172 against one another such that the composite assemblies 170A, 170B maintain their configurations.
  • Figs. 19A to 19C show perspective and side views of yet another outer shell assembly which incorporates a central support portion 190 with respective first and second support portions 192A, 192B.
  • the support portions 192A, 192B may generally comprise first and second angled supports 194A, 194B which are adjustably secured to respective first and second adjustable supports 196A, 196B which may be rotatable about first and second pivots 200A, 200B.
  • the adjustable supports 196A, 196B may each support respective first and second conformable portions 198A, 198B which provide a surface for supporting the bladder assembly against the patient.
  • adjustable supports 196A, 196B may be pivoted relative to the angled supports 194A, 194B to place the conformable portions 198A, 198B into contact with the patient's body. Once suitably positioned, the angled supports 194A, 194B and adjustable supports 196A, 196B may be locked in their configuration via securement pins 202A, 202B through any number of adjustment openings 204A, 204B.
  • FIGs. 20A and 20B show perspective and side views of a variation where a central support portion 210 and optional back support portion 212 may include a number of conforming supports 214A, 214B which may extend in a curved or arcuate manner from the central support portion 210 in a shaped shell configuration.
  • the conforming supports 214A, 214B may be shaped to conform more closely to the patient body PA while providing a stiff supporting platform for positioning the bladder assembly against the patient body PA.
  • conforming supports 214A, 214B may be extend in strips or members which are shaped, e.g., like flower petals, and the supports may be secured in place using any number of securement mechanisms, e.g., friction hinge mechanisms, electromechanical locking systems, hydraulic locking systems, magnetic locking systems, electro or magneto-rheological locking systems, etc.
  • securement mechanisms e.g., friction hinge mechanisms, electromechanical locking systems, hydraulic locking systems, magnetic locking systems, electro or magneto-rheological locking systems, etc.
  • Figs. 21A and 21B show perspective and side views of another variation similar to the embodiment of Figs. 20A and 20B .
  • one or more of the conforming supports 214A, 214B which are adjacent to one another may define overlapping regions 216 to provide a more contiguous platform.
  • outer shell assemblies are disclosed, various features between the different embodiments are intended to be utilized in any number of combinations as desired and as practicable.
  • the variation shown in Fig. 20A may incorporate any number of the support adjustment mechanisms such as columns, rotatable members, etc., in combination for adjusting the supports.
  • the features of the outer shell assembly shown in Fig. 22 may be used in combination with any of the outer shell assemblies or pad assemblies described herein.
  • the outer shell assembly may incorporate one or more zones 220, 222, 224, 226, 228 throughout various regions of the shell which may selectively or simultaneously squeeze, vibrate, or otherwise actuate, e.g., in the direction of actuation, vibration, or pulsation 230. These selective zones may vibrate at a selected frequency and/or amplitude and may be actuated at fixed intervals or times.
  • This actuation 230 can be automated based on a fixed interval/amplitude schedule or can be part of a closed loop system where depending on feedback from certain sensors (e.g., pressure, force, humidity, temperature, etc.) the outer shell can selectively be squeezed or vibrated by a certain amount to ensure that the sensor reading reach a predetermined levels.
  • each of the zones can be programmed to vibrate or squeeze in or out selectively or in some combination with each other. These zones may be actuated to squeeze against the patient body just enough to allow for pushing some of the fluid contained within the pad and/or pods, for example, below the sacrum and create a thin layer of fluid below the sacrum.
  • the outer shell may be sized to fit, e.g., more than 95 % of a target population, or the outer shell can be designed to be a one-size-fit-all or can be made in two or more different sizes to fit most of the patient population. This sizing can be applied to any of the various outer shell and pad assemblies described herein.
  • Figs. 23A and 23B show perspective views of yet another outer shell assembly which has a central support portion 240 with articulating and adjustable support portions.
  • the first and second conforming supports 242A, 242B may be anchored to the central support portion 240 and extend in a curved or arcuate shape for conforming more closely against the patient's body.
  • the supports 242A, 242B may each integrate one or more support members 244A, 244B which are adjacent to respective sliding supports 246A, 246B which may be tuned to push in or out relative to the central support portion 240 to adjust a rotation or bend radius of each support 244A, 244B independently of one another or simultaneously with each support 244A, 244B.
  • Each of the sliding supports 246A, 246B may be mounted on independent blocks which may be wedged independent to adjust a location of the supports 244A, 244B. Additionally, the sliding supports 246A, 246B may incorporate respective adjustable locks 248A, 248B to secure a position of the support to maintain a configuration of the conforming supports 242A, 242B.
  • the sliding supports 246A, 246B may be extended to position the conforming supports 242A, 242B in an opened configuration, e.g., for receiving a patient body. Once the patient has laid down within the assembly, the sliding supports 246A, 246B may be urged inward to place the conforming supports 242A, 242B against the patient. body, as shown in Fig. 23B .
  • Fig. 24A and 24B show end views of the conforming supports 242A, 242B when urged against the patient body PA.
  • any of the pad assemblies described herein may be used with this outer shell variation.
  • Fig. 24A illustrates how the bladder assembly may bottom out when a patient lies upon the outer pad 250 and is unsupported by the conforming supports 242A, 242B, as shown by the outward direction of support movement 256.
  • the patient body PA may compress the central portion of the pad resulting in a bottomed-out section 252 where the fluid within the pad form bulging sections 254 along the sides when displaced.
  • the fluid within the pad 250 along the previously bulging sections 254 may be "squeezed" or redistributed to flow beneath the patient body PA, as shown in Fig. 24B , to eliminate bottom-out section 252 and bulging sections 254.
  • one or more pressure sensors 259 may be disposed to detect bottoming out of the pad(s) and/or pods. If one area is bottoming out, then the pressure difference between the two sensors would be higher. The one or more pressure sensors 259 may be in contact with the pad(s) and/or pods.
  • One algorithm that can be used to detect bottoming out is to calculate the difference between two pressure sensors in contact with the fluid inside the bladder assembly, one of these pressure sensors can be located in a region that is expected to bottom out and the other pressure sensor can be located in a region that is not expected to bottom out. If neither area surrounding the pressure sensor is bottoming out, the pressure difference between the two sensors will be small due to the ability of the fluid to equalize pressure within the bladder assembly.
  • the one or more pressure sensors 259 can be used in a feedback loop with a controller 257 that controls an automated applied force 255 to squeeze the conforming supports 242A, 242B such that the patient body PA does not bottom out the pad(s) and/or pods when the patient sits or lies on the automated cushion assembly 253.
  • the redistribution of fluid within the pad 250 may help to reduce any pressure that may result below any bony prominences of the patient body.
  • the conforming supports 242A, 242B may be rotated or turned to conform more closely to the patient body PA, the fluid distribution may be improved to further reduce pressure beneath the patient.
  • Fig. 25 shows a perspective end view of another outer shell assembly having support portions 126A, 126B pivotably attached to respective central portions 122A, 122B which may have a fabric portion 124 attached between.
  • This variation may be configured such that the support portions 126A, 126B are arranged to be tangential relative to the patient body placed between.
  • the central portions 122A, 122B and fabric portion 124 may remain flattened beneath the patient's body while the support portions 126A, 126B may extend tangentially and conform to the patient's body.
  • the support portions 126A, 126B may further have a retaining lip or portion 282 pivotably attached via a respective hinge or pivot 280 which are able to be further angled relative to the patient's body, e.g., bent towards the patient's thigh on upon the thigh, to further squeeze or urge fluid within the bladder assembly 270 beneath the patient body and to further prevent fluid from bulging along the sides of the bladder assembly 270.
  • the retaining lip or portion 282 may omit any hinge or pivot and may simply comprise a flexible extension of the support portions 126A, 126B.
  • the outer shell assembly and bladder assembly may be designed to mimic the natural shape of the patient's hip region.
  • one or more adjustable straps 276 may be extend around the open portion of the shell assembly and also around the patient body to ensure that the assembly and retaining lip or portions 282 remain closely conformed and secured to the body.
  • the variation of the bladder assembly 270 shown placed upon the outer shell assembly may incorporate the inner pad and one or more pods throughout the entire bladder assembly, e.g., along the central portion as well as along the sides.
  • the inner pads 272A, 272B may be positioned within or beneath or above the assembly 270 along the support portions 126A, 126B.
  • the inner pads 272A, 272B may also contain one or more of the pods 274 within such that the pods 274 are in contact with one another to allow for the transmission of fluid pressure between the pods 274 while remaining contained (or restrained) within their respective inner pads 272A, 272B.
  • the one or more pods 274 may line support portions 126A, 126B and perform the function of achieving conformity with the patient body as well as redirect the fluid below the load bearing region of the patient.
  • the central portions 122A, 122B may have fabric portion 124 attached between, the two portions 122A, 122B may also be connected by one or more adjustment straps or rails 278 which may limit the movement between two portions 122A, 122B, as shown in the detail top view of Fig. 26 (with part of the bladder assembly 270 removed for clarity). Additionally, the straps or rails 278 may be adjustable to size the distance L between the supports 122A, 122B to more closely conform the shell assembly to the patient body. The distance L may be readjusted to the patient body, e.g., by using a sizing tool, or adjusted after the patient lies down upon the bladder and outer shell assembly using, e.g., a winch type mechanism or any other adjustment mechanism.
  • Figs. 27A and 27B show schematic end views of the outer shell assembly to illustrate how the support portions 126A, 126B and retaining lip or portions 282 may be wrapped or placed about a patient's body.
  • the support portions 126A, 126B may be seen in an open configuration (while optionally supported by supports 284 ) for receiving a patient body.
  • the one or more pods 274 are shown placed along the support portions 126A, 126B only although they may be placed along the central portion directly beneath the patient's body as well.
  • the inner pads and remaining bladder assembly (such as the outer pad) are not shown only for clarity.
  • the support portions 126A, 126B may be placed into contact against the sides of the patient's body such that one or more pods 274 are placed into supporting contact as well, as shown in Fig. 27B .
  • the retaining lip or portions 282 may be conformed, bent, or pivoted about their respective hinges (if hinges are used since they may be omitted entirely) such that the portions 282 are further wrapped around the patient's body, such as around their hips or thighs, to further conform against the body as well as to further prevent the fluid pressure or movement of the pods 274 from extending or bulging above the patient's body.
  • the entire assembly may be maintained in position and secured to the patient's body optionally by the use of the one or more adjustable straps 276 described above although the use of straps may be omitted entirely.
  • the retaining lip or portions 282 may be configured into various geometries as well. For instance, rather than being flattened segments, the portions 282 may be configured into curved sections where the one or more pods 274 and/or bladder assembly terminate within the curved ends. Moreover, the retaining lip or portions 282 may further incorporate a compression mechanism (such as screw-driven mechanisms, clamps, secondary fluid bladders, etc.) to further increase the compression of the portions 282 upon the pods 274 and/or bladder assembly.
  • a compression mechanism such as screw-driven mechanisms, clamps, secondary fluid bladders, etc.
  • the pressure of fluid within the bladder assembly can be an indicator of the optimal "squeeze" or compression of the support portions 126A, 126B on the patient's body. For instance, based on experimental testing, an optimal pressure range may be determined for each person based on his/her height and weight. If the fluid pressure is too low, this can be an indication of insufficient compression by the support portions 126A, 126B (or insufficient tension in the adjustable straps 276 if the straps are used to squeeze the support portions 126A, 126B upon the patient). Insufficient pressure within the bladder assembly can potentially lead to minimal fluid below the patient leading to bottoming out of the bladder assembly beneath the patient and thus causing localized regions of high pressure.
  • Such an algorithm can be derived based on a number of parameters but in one example, the following parameters may be taken into account. For example, weight of the patient; height of the patient; width of the patient's hip; gender; estimated sacrum weight; and optimal fluid pressure for the sacrum weight (provided by graphs, lookup tables, or other methods).
  • fluid pressure can be determined using, e.g., a pressure gauge which can be removed or attached to the person, a turkey-popper type indicator, any other similar pressure gauges, etc.
  • the internal bladder pressure is simply one indicator which may be used to monitor pressure.
  • Other indicators which may also be used in the alternative or in addition to the internal bladder pressure may optionally utilize measurement of, e.g., strap tension, squeeze force/pressure along the support portions (e.g., by attaching pressure/force sensors), as well as other mechanisms.
  • FIG. 28 illustrates an outer shell assembly having a bladder assembly with a pressure gauge 286 fluidly coupled by a fluid line 288 for determining the pressure of the fluid, for instance, before and/or after the assembly is secured to a patient.
  • securing the outer shell assembly to a patient body may be accomplished in number of different ways.
  • One example may include the following steps: (1) the nurse or health care provider may size the patient and notes the weight and height of the patient; (2) the nurse or health care provider may set the distance between the central portions 122A, 122B; (3) the nurse or health care provider may slide the assembly beneath the patient body; (4) the nurse or health care provider may then initially adjust the support portions 126A, 126B against the patient's body while monitoring the pressure indicator until an optimal fluid pressure is reached for the patient based on their parameters such as their height and weight; and (5) the nurse or health care provider may then readjust the outer shell assembly, bladder assembly, or fluid pressure, etc. based on patient comfort and feedback, if provided.
  • the system may be automatically operable to adjust one or more regions or segments of the assembly in either a completely automated or semi-automated manner.
  • Fig. 29 shows how the different regions or portions of the outer shell assembly may be adjusted to minimize the pressure placed upon or imparted upon the patient body.
  • One or more regions of the outer shell assembly and/or bladder assembly may incorporate any number of pressure indicators which are in communication with a controller. The controller may actively monitor these various regions of pressure and accordingly adjust the assembly to minimize or maintain the pressure imparted upon the patient body, e.g., below a predetermined threshold.
  • the adjustments to the assembly may be done automatically or semi-automatically when a nurse or care provider adjusts or places the assembly upon the patient.
  • the system may accordingly adjust the device automatically relative to the patient body or it may provide feedback to the nurse or care provider to make the adjustments.
  • the various regions of the assembly 120 may be adjusted, e.g., support portions 126A, 126B; conformable portions 130A, 130B; back support portion 128; etc., relative to the central portion 122 as indicated by the direction of movement/rotation 290, 292 and/or direction of movement/actuation 294, 296. These adjustments may be accomplished using any of the various adjustment features described herein.
  • the one or more regions of the assembly 120 may be adjusted by the nurse or care provider. Additionally and/or alternatively, in the case of a fully automated system, one or more actuators 298A, 298B (e.g., motors, pneumatic or hydraulic actuators, etc.) coupled to the various regions may be used to make the appropriate adjustments.
  • actuators 298A, 298B e.g., motors, pneumatic or hydraulic actuators, etc.
  • any of the pressure indicators described herein may be used. Additionally and/or alternatively, various other pressure or force sensors (e.g., resistive or capacitive type sensors) may be placed in particular regions of the patient body such as those areas of bony prominences such as the sacrum and trochanter. Optionally, any number of sensors may be positioned in a matrix over the entire surface of the outer shell assembly or bladder assembly or a separate pressure indicator. In any of these variations, the one or more sensors may be placed in communication with a controller which can be programmed with a preset pressure profile.
  • a controller which can be programmed with a preset pressure profile.
  • a preset pressure level may be initially programmed into the controller 302 which may monitor and calculate any differences in the monitored pressure levels via any embodiment of the pressure sensor 306 in contact or communication with any region of the patient body.
  • the measured pressure by the pressure sensors 306 may be compared by the controller 302 to determine whether the particular measured pressure is beyond the set pressure level. If not, then the controller 302 may simply maintain a position of the assembly relative to the patient body; however, if a calculated difference is beyond the set pressure level, then the controller 302 may send a control signal to the relative actuator to adjust the relevant portion of the outer shell 304 until the measured pressure levels fall within the predetermined limits.
  • the controller 302 may provide an indication, alert, and/or message displayed to the nurse or care provider to adjust a particular portion of the outer shell 304 until the monitored pressure falls within the predetermined limits.
  • pressure sensors may be used (e.g., (resistive, capacitive, piezo-based, hydraulic, etc.).
  • force sensors may also be utilized, e.g., FlexiForce® Sensors (Tekscan, Inc., Boston , MA).
  • sensors may also be utilized, e.g., skin oxygen sensors or skin perfusion indicators, temperature sensors, humidity sensors, heart rate sensors, breathing sensors, accelerometers, gyroscopes, etc.
  • Fig. 31A schematically illustrates one variation for implementing a feedback loop to the outer shell assembly 120 and/or bladder assembly 140.
  • one or more pressure sensors may be positioned within the bladder assembly 140 or in communication with the bladder assembly 140 to provide one or more pressure sensor readings 310 at one or more corresponding positions over the bladder assembly 140. These readings 310 may be transmitted to the controller 312 which may be optionally programmed to compare the measured readings 310 relative to a preprogrammed value.
  • the controller 312 may send a signal to one or more pumps or regulators 314 in communication with the bladder assembly 140 (e.g., in communication with either the inner pad 142, outer pad 144, or the one or more pods 146, individually or collectively) to increase or decrease a volume of fluid within any one or all of the components of the bladder assembly 140 or particular regions or portions of the bladder assembly 140.
  • one or more pumps or regulators 314 in communication with the bladder assembly 140 (e.g., in communication with either the inner pad 142, outer pad 144, or the one or more pods 146, individually or collectively) to increase or decrease a volume of fluid within any one or all of the components of the bladder assembly 140 or particular regions or portions of the bladder assembly 140.
  • the pump or regulator 314 can instead selectively direct fluid within the bladder assembly 140 to areas of sensed high pressures from areas of sensed low pressures.
  • This selective and directional fluid flow can be accomplished by any number of mechanisms.
  • FIG. 31B shows how the controller 312 may be in communication with one or more individual fluid pods 316 (e.g., positioned along the central portion beneath the patient body) which may each be selectively inflated or deflated by adding or removing fluids such as air or water.
  • the relative inflation and deflation of the one or more pods 316 may be used to control the amount of fluid present in the portion of the main bladder above the pods 316.
  • Figs. 32A and 32B show exemplary side views of how the individual fluid pods 316A, 316B, 316C may be initially inflated at the same pressure such that the outer pad 144 above is maintained at a uniform level for supporting the patient body (the inner pad is omitted for clarity although the inner pad may be omitted entirely in this variation).
  • the controller 312 detects a region 318 of high pressure exerted upon the bladder assembly 140 by the patient body, the fluid pod 316B directly below that high pressure region may be deflated while the surrounding pods 316A, 316C adjacent to pod 316B may inflated to direct the fluid within the pad 144 towards the high pressure region to provide additional support to the patient body. While one example is illustrated for directing the fluid beneath regions of the patient body, alternative mechanisms may also be used in other variations.
  • a typical algorithm 320 for a self-adjusting system which may be implemented to any of the shell assemblies described herein is illustrated in Fig. 33 .
  • the algorithm can use feedback from the pressure sensors or force sensors embedded throughout the assembly or the algorithm can take feedback from other parameters such as temperature, humidity, heart rate or breathing rate of the patient.
  • the pressure limits may initially set 322 and programmed in the controller 324.
  • the outer shell assembly 120 or bladder assembly 140 (or pods 316 as previously described) may be modulated or adjusted to initially achieve the set pressure levels 326 when the outer shell assembly 120 is first conformed to the patient body.
  • the controller 324 in communication with the sensors, may send a signal to the one or more pumps or regulators 314 adjust the pressure levels against the patient body by adjusting the outer shell assembly 120, bladder assembly 140, or pods 316 individually or collectively. Otherwise, if the monitored pressure levels remain below the set pressure level, then no adjustments may be needed 332 unless or until the sensed pressure levels rise above the preset pressure levels.
  • Fig. 34 illustrates another algorithm 340 in which the outer shell assembly 120, bladder assembly 140, or pods 316 are adjustable semi-automatically, e.g., by a nurse or caretaker.
  • the nurse or caretaker 342 may set an initial pressure level 344 and modulate or adjust the outer shell assembly 120, bladder assembly 140, or pods 316 against the patient body based in part on patient comfort 346.
  • the pressure sensors may monitor or sense the actual pressures imparted by the patient against the device 348. If the sensed pressure is determined to be greater than the level set by the nurse or caretaker 350, the outer shell assembly 120, bladder assembly 140, or pods 316 (individually or collectively) may automatically adjust as described above.
  • an alert, indication, or message may be displayed visually and/or audibly to the nurse to caretaker that the outer shell assembly 120, bladder assembly 140, or pods 316 should be adjusted to bring the sensed pressure levels below the preset values. If the nurse or caretaker does adjust any one or all of the components, then the sensed or detected pressure values may be monitored and displayed or indicated accordingly until the pressure levels fall below their preset levels, in which case any further adjustments may be stopped 352.
  • the system can be pre-programmed to alternate pressures by adjusting the stiffness of the bladder assembly 140 by the inflation and/or deflation of different pods as individual elements or collectively as a group.
  • different regions of the outer shell assembly 120 and/or bladder assembly 140 can be divided into different zones in which the pressure can be alternated independently, as previously described.
  • the fluid within the bladder assembly 140 may be continuously circulated at a predetermined rate to cause turbulence in the fluid. This turbulence leads to lower pressures.
  • small silicone or glass beads can be filled inside of the bladder assembly 140 and the fluid can be circulated continuously which causes the beads to float or move leading to lower pressures in the target anatomy.
  • particular regions of system may be programmed by the controller to alternate the set pressure level to provide pressure relief against the patient body.
  • ceratin zones may be alternated below a set pressure (e.g., 30 mmHg, 20 mmHg, 10 mmHg, etc.) for predetermined periods of time.
  • the controller can take inputs relating to the patient's biometric information such as the height, weight and other parameters and the predetermined time intervals also can be determined to be a function of the rate of perfusion. This alternating feature may be implemented in any of the variations of the system described herein.
  • the system may be programmed to simulate a rocking motion or other periodic motion upon the patient body.
  • the periodic rocking or movement may be imparted upon the patient body to allow for pressure reduction and better perfusion rates along the contacted regions of the body.
  • this rocking motion can be achieved, e.g., by movement of the rails, supports, etc., or by vibration of particular regions of system (e.g., outer shell assembly 120, bladder assembly 140, or pods 316), as also described above.
  • the vibrating or rocking feature may be actuated based on a number of different criteria. For instance, it may be initiated by a controller periodically based on a set time interval or it may manually initiated by the caretaker or directly by the patient. Alternatively, the controller may be programmed to initiate the motion based on external feedback such as patient inactivity over a particular time period, camera feedback, etc. Additionally, such a feature may also be implemented in any of the variations of the system described herein.
  • the senor may be configured as an indicator for detecting whether any region of the bladder assembly 140 and/or pods 316 are bottoming-out.
  • one or more of the sensors can be configured to give an indication or feedback on whether any of the bladder assemblies and/or pods have compressed and completely displaced the fluid beneath the patient body which may lead to high pressures. Sensing of bottoming-out can be done, for example, by calculating the difference in pressure readings from pressure sensors that measure the pressure inside the bladder assembly 140 and/or pods 316 when they are not bottoming out, but which would measure patient contact pressure when the patient did bottom out.
  • Fig. 35 illustrates a wheelchair cushion assembly 350
  • the wheelchair cushion assembly 350 includes one or more central support sections 122A, 122B, support sections 126A, 126B, bladder assembly 140, retaining lip or portions 282A, 282B, inner pads 272, a plurality of pods 274, and retaining lips or portions 282A, 282B. These components of the wheelchair cushion assembly 350 function in a similar manner to the corresponding components in other embodiments described in this application.
  • the wheelchair cushion assembly 350 further comprises attachment plates or straps 352 that secure the central support section to a wheelchair (not shown).
  • the wheelchair design can also include a lower cushioning layer 353.
  • the lower cushioning layer 353 can have a thickness of 1 to 15 cm and can comprise compressible material such as foam, gels, or oils.
  • the lower cushioning layer 353 may comprise a plurality of springs.
  • the bladder assembly 140 comprises ergonomic contouring 354 and 356 that better shape the cushion to the patient. Ergonomic contouring may be a recessed 356 or cutout 354 portion of the bladder that helps to improve the stability of the patient while maintaining or improving the distribution of pressure on the patient.
  • the wheelchair cushion assembly 350 further comprises a fill port 358 that can be connected to a pump to manually or automatically adjust the pressure of fluid within the bladder assembly 140 and/or within the inner pads 272, independently or in combination.
  • Stability and pressure are two important aspects of a wheelchair seat cushion assembly.
  • the plurality of pods 274 provide stability for those patients who are lighter than average while still providing some cushioning.
  • the plurality of pods 274 provides cushion and the compliant inner pads 272 are configured to provide a larger spring constant when the extension of the pods exceeds a certain threshold.
  • the fluid in the sealed bladder assembly 140 can be configured such that the liquid is forced to migrate to the areas without pods which increases the relative pressure on the portions of the patient's anatomy not cushioned directly by the plurality of pods 274.
  • the inner pads 272 can be attached to the bladder assembly 140 or attached to each other within the bladder assembly 140 to provide additional stability to the patient when seated on the wheelchair cushion assembly 350.
  • Fig. 36A shows an enhancement of the wheelchair cushion assembly 350.
  • a back support 362 is attached to (or deposed adjacent to) the wheelchair cushion assembly 350 to form a wheelchair cushion assembly with back support 360 that provides improved pressure distribution for the patient's seat and back regions relative to the wheelchair cushion assembly 350.
  • the back support 362 may comprise back support portions 364, a plurality of back pods 366, and inner back pads 368.
  • the addition of the back support 362 allows additional pressure distribution within the bladder assembly 140 as additional pressure from the seat area is redistributed to the back portion of the assembly 360.
  • the wheelchair cushion assembly 350 or wheelchair cushion assembly with back support 360 can be disposed onto a wheelchair 361.
  • the assembly 350 or 360 can be resting on the wheelchair 361 or firmly attached via screws, bolts, straps, or other attachment means that attach, permanently or temporarily, the wheelchair 361 to the attachment plates or straps 352 (as shown in Fig. 35 ).
  • Adjustable support assemblies can be integrated into a mattress or can be an accessory to a standard mattress. Figs. 37 , 38 , 39A , and 39B show examples of such embodiments. Adjustable support assemblies may sit on top of the mattress or sit in a recess of the mattress that is specifically designed for the support structure. A plurality of support regions may be positioned to provide independently adjustable support for two or more of the following regions of the body a person who would lie upon the mattress with support structure disposed upon it, e.g., pelvic region, ischium region, head, feet, heels, torso, shoulders, and/or elbow, etc.
  • Fig. 37 shows a plurality of adjustable support assemblies 372A, 372B , and 372C disposed upon a mattress 379.
  • the adjustable support assemblies 372A, 372B, and 372C are shaped to accommodate regions of a patient's anatomy, such as the head (e.g. assembly 372A), pelvis (e.g., assembly 372B), and/or feet (e.g., assemblies 372C).
  • the individual shaping of adjustable support assemblies to accommodate specific regions of the patient's anatomy allow for better stability by allowing less fluid to be used in a design. This is particularly true when a design is sold to the consumer without expensive customization for individual sizing and fitting.
  • a conformal pillow 370 may be built into the mattress to allow further support for the patient's head.
  • Fig. 38 shows one such configuration. This configuration likely requires slightly more fluid than the embodiment illustrated in Fig. 37 , but it allows for increased flexibility in the ways in which the patient can be positioned.
  • a plurality of adjustable support assembly segments runs nearly the length of the bed. These adjustable support assembly segments each comprise a segmented adjustable support portion 380 and segmented bladder assembly 382. Five segments are depicted in Fig. 38 . In other embodiments, 3 to 100 segments could be used.
  • FIG. 39A and 39B Exemplary cross sections of the embodiments of Fig. 37 and 38 are shown in the perspective views of Figs. 39A and 39B .
  • the mattress 379 is intended to be a mattress with a flat top.
  • Figs. 39A and 39B illustrate slightly variations in which a recessed mattress 390 is used.
  • the individual adjustable support assemblies 372A, 372B, and 372C or segmented adjustable support sections 380 each comprise a plurality of pods 376, which are contained within a plurality of inner pads 377.
  • the plurality of inner pads is contained within or disposed upon a bladder assembly 378.
  • the plurality of pods 376, inner pads 377, and bladder assembly 378 components are supported by support portions 374 and each of these components functions in a similar manner to the corresponding components in other embodiments described in this application.
  • the adjustable support assemblies are disposed on a mattress 379 or on a recessed mattress 390.
  • the adjustable support assemblies may be attached to a mattress by a manufacturer or may be a separate assembly that is placed on a mattress by the user or caregiver.
  • the recessed contour 392 in the recessed mattress 390 provides additional stability for the patient because it restricts the movement of an adjustable support assembly relative to the recessed mattress 390.
  • the recess contour 392 may provide additional support for the adjustable support portions 394 as shown in Fig. 39A or may serve in place of the adjustable support portions 394 as shown in Fig. 39B .
  • One advantage of the configuration shown in Fig. 39B is that the top of the mattress can be flat, which allows the use of normal bedding materials.
  • the support portions 374 and 394 can be configured such that they can be moved, by the patient or a caregiver, into a flat position or laterally inward or outward, which can make it easier for the patient to get into and out of the bed.
  • the mattress 379 or recessed mattress 390 may be of many different types.
  • a spring mattress a foam mattress, a low air loss mattress, a segmented air mattress, a cyclical air pressure mattress, a water bed, or a bed of air supported glass beads may be used.
  • Fig. 40A shows an assembly which utilizes a support which is independent of one another so as to allow for unrestricted adjustability relative to the sides of a patient's body.
  • the support assembly 400 has an outer pad assembly 402 which is positionable partially or entirely over or upon a first support portion 404 and a second support portion 406 which is adjustably apposed to the first support portion 404. Adjusting a position of the first support portion 404 and the second support portion 406 may allow for the outer pad 402 to be adjusted in for optimizing the support provided against the sides of (and beneath) the patient's body.
  • Fig. 40B shows a perspective assembly view of some of the components of the support assembly 400.
  • the outer pad 402 as described in further detail below, comprises a fluid or gas filled layer embodied in any of the variations described above.
  • the first support assembly 404 may generally comprise a support platform 408 upon which a first conforming support member 418 may be secured.
  • the conforming support 418 may be comprised of a relatively soft material such as foam which may be shaped into various sizes and covered in a soft, breathable, and stretchable covering 422 which may be optionally water resistant and antibacterial (e.g., Gore-Tex®, BrookWood's Derma Plush®, Eastex Fabrics Tek Stretch).
  • the conforming support 418 may be secured upon the first support platform 408 and define a surface upon which the one or more pods 416 may be positioned linearly adjacent to one another for placement against the patient's side.
  • the one or more pods 416 are enclosed by an inner layer or pad 412 which may enclose the one or more pods 416 and, as previously described, the inner layer or pad 412 may be devoid of fluid and constrain the expansion of the individual pods.
  • inner layer or pad 412 may be optionally vented to allow for any trapped air to vent from between the pods 416 when the pods 416 undergo compression when placed against the patient's body.
  • the second support assembly 406 may be similarly constructed of a support platform 410 upon which a second conforming support member 420 may be covered in covering 422.
  • the support member 420 may be configured for likewise present a surface upon which the one or more pods 416 are aligned and enclosed by inner layer or pad 414.
  • the second support assembly 406 is shown where the conforming support member 420 may be shaped into a tapered support which presents a transverse or angled surface upon which the inner layer or pad 414 may be attached.
  • the one or more pods 416 may be aligned (shown in this example as five fluid pods although fewer than five or greater than five pods may be used) against this presentation surface and constrained by the inner layer or pad 414.
  • the inner layer or pad 414 may be devoid of fluid but instead constrain the expansion of the individual pods 416.
  • the entire inner layer or pad 414 and the pods 416 constrained within may be covered by a fabric covering, as described above.
  • the shapes of the support member 420 as well as platform 410 may be varied depending upon the desired design and conformability against the side of the patient's body.
  • a securement strip 426 (e.g., hook-loop fastener strip) may also be provided along the covering 422 or support member 420 for securing the support assemblies and outer pad 402 to one another.
  • Figs. 42A and 42B show perspective views of the assembly.
  • This particular variation of the outer pad 402 may optionally incorporate the pods along portions of the pad or throughout the entire pad if so desired.
  • the pods are omitted but the outer pad 402 be a continuous bladder filled with any number of fluids or gases (or both) through the entire layer as previously described above (e.g., mineral oil or any other similar low density fluids, water, mixture of water or oil, additional microspheres or beads in composition with the water, oil, or both to create a composite low density fluid mixture, etc.).
  • fluids or gases e.g., mineral oil or any other similar low density fluids, water, mixture of water or oil, additional microspheres or beads in composition with the water, oil, or both to create a composite low density fluid mixture, etc.
  • the outer pad 402 may be sized to have different lengths (e.g., 28 inches although pad 402 may be shorter or longer, for example, to extend across the width of a bed) so long as the outer pad 402 is sufficiently long enough to provide support beneath the patient's body when positioned upon the supports 404, 406 as described above.
  • the outer pad 402 may be situated upon the supports 404, 406 such that the pressure from the patient's body may be transferred between the outer pad 402 and pods 416 and through the inner layer or pad 412, 414.
  • the outer pad 402 may be optionally secured and enclosed within a covering 430 which may be a soft, breathable, and stretchable covering as described above. Moreover, the covering 430 (and/or outer pad 402) may be secured to a support layer 432 which may be comprised of a fabric layer (which may be non-stretching). The covering 430 may also include micro-climate management layers (eg. thinsulate, primaloft or similar insulating fabrics). The covering 430 may be optionally attached (removably or permanently) along the entire length of the support layer 432 or the covering 430 may be attached alternatively along a central portion 434.
  • a covering 430 which may be a soft, breathable, and stretchable covering as described above.
  • the covering 430 (and/or outer pad 402) may be secured to a support layer 432 which may be comprised of a fabric layer (which may be non-stretching).
  • the covering 430 may also include micro-climate management layers (eg. thinsulate, primalof
  • the outer pad 402 may also incorporate one or more securement strips 436 (e.g., hook-loop fastener strip) for corresponding attachment to the securement strips 426 positioned along supports 404, 406.
  • securement strips 436 e.g., hook-loop fastener strip
  • any of the materials or components may be incorporated into the adjustable variation.
  • any of the controllers, one or more pressure sensors, and/or actuators described above may be fully incorporated into, upon, or within any of the layers, pads, or the support portions 404,406 if so desired.

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nursing (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Invalid Beds And Related Equipment (AREA)
EP13857489.2A 2012-11-21 2013-10-18 Adjustable support system Active EP2922507B1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13/683,198 US9339407B2 (en) 2011-07-22 2012-11-21 Apparatus and methods for conforming a support to a body
US13/693,691 US9326905B2 (en) 2011-07-22 2012-12-04 Apparatus and methods for adjusting a support to a body
US13/760,482 US20130180530A1 (en) 2011-07-22 2013-02-06 Adjustable support system
US13/784,035 US10485691B2 (en) 2011-07-22 2013-03-04 Independently adjustable support system
US13/945,684 US20130298918A1 (en) 2011-07-22 2013-07-18 Independently adjustable support system
PCT/US2013/065641 WO2014081521A2 (en) 2012-11-21 2013-10-18 Adjustable support system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP17185768.3 Division-Into 2017-08-10

Publications (3)

Publication Number Publication Date
EP2922507A2 EP2922507A2 (en) 2015-09-30
EP2922507A4 EP2922507A4 (en) 2016-06-22
EP2922507B1 true EP2922507B1 (en) 2017-09-20

Family

ID=50776657

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13857489.2A Active EP2922507B1 (en) 2012-11-21 2013-10-18 Adjustable support system

Country Status (6)

Country Link
EP (1) EP2922507B1 (ja)
JP (1) JP2015536199A (ja)
CN (1) CN104918588B (ja)
BR (1) BR112015011659A2 (ja)
CA (2) CA3192226A1 (ja)
WO (1) WO2014081521A2 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9326905B2 (en) 2011-07-22 2016-05-03 Prs Medical Technologies, Inc. Apparatus and methods for adjusting a support to a body
US9339407B2 (en) 2011-07-22 2016-05-17 Prs Medical Technologies, Inc. Apparatus and methods for conforming a support to a body
US10485691B2 (en) 2011-07-22 2019-11-26 Prs Medical Technologies, Inc. Independently adjustable support system
GB2536638A (en) * 2015-03-23 2016-09-28 Talar-Made Ltd An apparatus for reducing contact pressure on a person, a bed in combination with an apparatus and a method of preparing a bed
US10413464B2 (en) * 2015-05-05 2019-09-17 Hill-Rom Services, Inc. Multi-mode sacral unloading pressure relief in a patient support surface
CN106937809B (zh) * 2017-04-14 2024-06-14 哈尔滨紫冉科技开发有限公司 可变换承重部位的坐垫及变换控制方法
CN107049667B (zh) * 2017-06-08 2019-07-23 张龙起 一种放置在病床上用于保护糖尿病病人足部的保护架
DE102018102107A1 (de) * 2018-01-31 2019-08-01 ReActive Robotics GmbH Manschette zur Aufnahme wenigstens eines Teils einer äußeren Extremität einer Person
DE102018203443A1 (de) * 2018-03-07 2019-09-12 Bauerfeind Ag Mobilisierende Hüftorthese
DE102019105532A1 (de) * 2018-09-27 2020-04-02 FortHi GmbH Auflageeinrichtung zur Auflage eines Körperteils eines Nutzers
ES2977286T3 (es) * 2019-01-25 2024-08-21 Rc Services Australia Pty Ltd Cojín de soporte
CN115300289B (zh) * 2022-10-13 2023-01-13 管培杰 一种患者术后换药辅助护理支撑装置
EP4458338A1 (en) * 2023-05-02 2024-11-06 Mölnlycke Health Care AB A moldable pad assembly for supporting a body part

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4836194A (en) * 1986-08-29 1989-06-06 Safeguard Industrial Corporation Therapeutic lumbosacral appliance
JPH01175848A (ja) * 1987-12-29 1989-07-12 Japan Medical Dynamic Marketing Inc 傾動式マット
US4934002A (en) * 1989-06-20 1990-06-19 Kabushiki Kaisha Nihon M.D.M. Tiltable mat assembly
US5400803A (en) * 1992-07-22 1995-03-28 Tracy Medical Resources, Inc. Apparatus for support or positional treatment
US5843008A (en) * 1996-12-10 1998-12-01 Gerhard; Harvey Method for mitigating pain when coughing following surgery
CA2409256C (en) * 2000-05-19 2009-12-22 The Research Foundation Of State University Of New York Semi-rigid pelvic compression splint for trauma
JP2002126013A (ja) * 2000-10-20 2002-05-08 Keepu:Kk エアマット装置
KR20020066764A (ko) 2001-02-13 2002-08-21 박창준 추간판탈출증 치료용 의료보조기
US6598251B2 (en) * 2001-06-15 2003-07-29 Hon Technology Inc. Body support system
JP2007289518A (ja) * 2006-04-26 2007-11-08 Satoru Yoshimura 床ずれ防止用介護用具
US8109892B2 (en) * 2007-04-09 2012-02-07 Tyco Healthcare Group Lp Methods of making compression device with improved evaporation
CN101336852B (zh) 2008-08-12 2011-06-22 吴亚军 一种充气腰带
JP4790082B2 (ja) * 2009-12-16 2011-10-12 和夫 大場 傾斜面を有する寝具用空気袋
US8578941B2 (en) * 2010-01-08 2013-11-12 Mitchell V. Kaminski Slipper-like device to prevent or help heal pressure ulcers of the foot
US20110239372A1 (en) * 2010-03-31 2011-10-06 Bhat Nikhil Personal support device that provides uniform distribution of pressure on a body portion
US8656919B2 (en) 2011-07-22 2014-02-25 Prs Medical Technologies, Inc. System for prevention and treatment of pressure ulcers
US20130255699A1 (en) * 2012-04-02 2013-10-03 TurnCare, Inc. Patient-orienting alternating pressure decubitus prevention support apparatus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
CA2892048C (en) 2023-05-09
EP2922507A2 (en) 2015-09-30
EP2922507A4 (en) 2016-06-22
CA2892048A1 (en) 2014-05-30
JP2015536199A (ja) 2015-12-21
CA3192226A1 (en) 2014-05-30
CN104918588B (zh) 2017-10-27
CN104918588A (zh) 2015-09-16
WO2014081521A2 (en) 2014-05-30
WO2014081521A3 (en) 2014-07-17
BR112015011659A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
US11446171B2 (en) Independently adjustable support system
EP2922507B1 (en) Adjustable support system
US20130180530A1 (en) Adjustable support system
US9326905B2 (en) Apparatus and methods for adjusting a support to a body
US9339407B2 (en) Apparatus and methods for conforming a support to a body
US8656919B2 (en) System for prevention and treatment of pressure ulcers
US8887732B2 (en) Method and devices for prevention and treatment of pressure ulcers
US9750655B2 (en) Conformable support system
US20220347027A1 (en) Devices and Methods to Help Prevent Decubitus Ulcers
US11937706B2 (en) Adjustable mattress assembly
US20140284988A1 (en) Seating aids for paralyzed individuals
WO2019079557A1 (en) DOUBLE USE MATTRESS WITH PNEUMATIC MATTRESS AND VISCOELASTIC FOAM FOR PATIENT CARE
RU2808811C2 (ru) Устройство для позиционирования тела пользователя и способ управления данным устройством
KR20210126941A (ko) 욕창 방지 매트

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150618

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LIN, STUART

Inventor name: LI, ALLEN J.

Inventor name: JACKSON, JASPER

Inventor name: CHOI, GEORGE Y.

Inventor name: BHAT, NIKHIL

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20160525

RIC1 Information provided on ipc code assigned before grant

Ipc: A61G 7/10 20060101ALI20160519BHEP

Ipc: A61F 5/37 20060101AFI20160519BHEP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602013026985

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61F0005370000

Ipc: A61G0007065000

RIC1 Information provided on ipc code assigned before grant

Ipc: A61G 7/10 20060101ALI20170222BHEP

Ipc: A61F 5/37 20060101AFI20170222BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61G 7/065 20060101AFI20170307BHEP

INTG Intention to grant announced

Effective date: 20170331

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 929589

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013026985

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171220

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 929589

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171221

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171220

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180120

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602013026985

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171018

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171031

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20171031

26N No opposition filed

Effective date: 20180621

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171018

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20131018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170920

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230920

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240919

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240919

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20240919

Year of fee payment: 12